Product Information
BACLOFEN 25 MG/5 ML SUSPENSION is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $3.7681 per ML under NDC 52536060011. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Feb 4, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the baclofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536060011
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BACLOFENApproval Type
Authorized Generic (NDA)
FDA Application
NDA215602FDA Approved
2/4/2022
TE Code
AB
On Market Since
4/1/2023
Pharmacological Classes
Price Statistics
The NADAC for BACLOFEN 25 MG/5 ML SUSPENSION has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 28.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7681 per ML |
|---|---|
| All-time high | $5.2947 (May 15, 2024) |
| All-time low | $3.7219 (Jul 22, 2026) |
| 52-week high | $4.1217 |
| 52-week low | $3.7219 |
| Median price | $4.0594 |
| Average price | $4.1095 |
| Largest weekly change | -14.8% (May 22, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BACLOFEN 25 MG/5 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for BACLOFEN 25 MG/5 ML SUSPENSION, manufactured by Wilshire Pharmaceuticals Inc., is $3.7681 per ML (NDC 52536060011), effective Aug 19, 2026.
How has the price of BACLOFEN 25 MG/5 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for BACLOFEN 25 MG/5 ML SUSPENSION has declined 28.8%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for BACLOFEN 25 MG/5 ML SUSPENSION?
Since Apr 17, 2024, the NADAC for BACLOFEN 25 MG/5 ML SUSPENSION has ranged from a low of $3.7219 (Jul 22, 2026) to a high of $5.2947 (May 15, 2024), with a median of $4.0594 per ML.
Are there cheaper alternatives to BACLOFEN 25 MG/5 ML SUSPENSION?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BACLOFEN 25 MG/5 ML SUSPENSION in a comparable dosage form, but none are currently priced below it.
Who manufactures BACLOFEN 25 MG/5 ML SUSPENSION?
BACLOFEN 25 MG/5 ML SUSPENSION (NDC 52536060011) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.